» Authors » Davide De Leoni

Davide De Leoni

Explore the profile of Davide De Leoni including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 12
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Vizzuso A, Renzulli M, Lancellotta V, Posa A, Cornacchione P, Fionda B, et al.
Cancers (Basel) . 2025 Jan; 16(24. PMID: 39766082
This study systematically reviews the efficacy and safety of combining transarterial embolization (TAE) with radiotherapy (RT) for managing bone metastases (BM), assessing clinical response (CR), and local control (LC). A...
2.
Alexandre A, Monforte M, Brunetti V, Scarcia L, Cirillo L, Zini A, et al.
Int J Stroke . 2024 Mar; 19(7):779-788. PMID: 38546177
Background: Recent randomized trials have shown the benefit of mechanical thrombectomy (MT) also in patients with an established large ischemic core. Aims: The purpose of this study was to define...
3.
Alexandre A, Scarcia L, Brunetti V, Scala I, Kalsoum E, Valente I, et al.
J Neurointerv Surg . 2023 Dec; 17(e1):e87-e95. PMID: 38129110
Background: The aim of our study was to find predictors of parenchymal hematoma (PH) and clinical outcome after mechanical thrombectomy (MT) in patients with large vessel occlusion (LVO) and baseline...
4.
Milano A, Capotosti A, Zagaria L, Perotti G, Rizzo A, Longo V, et al.
Curr Radiopharm . 2023 Jun; 16(4):326-336. PMID: 37291781
Background: Transarterial Radioembolization (TARE) is a widespread radiation therapy for unresectable hepatic lesions, but a clear understanding of the dose-response link is still missing. The aim of this preliminary study...
5.
Punzi E, Carrubba C, Contegiacomo A, Posa A, Barbieri P, De Leoni D, et al.
Life (Basel) . 2023 Mar; 13(3). PMID: 36983990
Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease; patients' long-term survival is strictly linked to the surgical resection of the tumor but only a minority of patients (2-3%) have a...
6.
Iezzi R, Posa A, Caputo C, De Leoni D, Sbaraglia F, Rossi M, et al.
Life (Basel) . 2023 Mar; 13(3). PMID: 36983788
Interventional Oncology treatments grant low-risk mini-invasive alternatives to surgery for cancer patients. Percutaneous ablative therapies represent a cornerstone for treatment of liver cancer patients. Among these, a newly emerging one...
7.
Iezzi R, Gangi A, Posa A, Pua U, Liang P, Santos E, et al.
Cancers (Basel) . 2023 Jan; 15(1). PMID: 36612304
Interventional oncology (IO) employs image-guided techniques to perform minimally invasive procedures, providing lower-risk alternatives to many traditional medical and surgical therapies for cancer patients. Since its advent, due to rapidly...